Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
NCT ID: NCT02239237
Last Updated: 2018-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30283 participants
OBSERVATIONAL
2014-09-30
2018-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-marketing Safety and Efficacy Surveillance of Motherwort Injection
NCT06636422
Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.
NCT04479553
A Registry Study on Safety Surveillance of Dazhuhongjingtian (a Chinese Medicine Injection) Used in China
NCT03189199
Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study
NCT01872520
Safety Study of Shenfu (a Chinese Medicine Injection) Used in Hospitals in China
NCT01612533
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Compound Kuh-seng Injection
Compound Kuh-seng Injection will be given to the patients, and the investigators will record all the information including ADR, application of Compound Kuh-seng Injection and the combined medications, etc.
Compound Kuh-seng Injection
Compound Kuh-seng Injection is a kind of natural compound injection extracted from Chinese herbs Kuh-seng (Radix Sophorae Flavescentis) and Rhizoma Heterosmilacis Japonicae. The major bioactive ingredients include oxymatrine，sophocarpidine, matrine, flavonoid etc.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Compound Kuh-seng Injection
Compound Kuh-seng Injection is a kind of natural compound injection extracted from Chinese herbs Kuh-seng (Radix Sophorae Flavescentis) and Rhizoma Heterosmilacis Japonicae. The major bioactive ingredients include oxymatrine，sophocarpidine, matrine, flavonoid etc.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanxi Zhendong pharmaceutical Co. LTD.
UNKNOWN
Zhong Wang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhong Wang
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhong Wang, M.D.
Role: STUDY_DIRECTOR
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Zhan-Yu Pan, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Tianjin medical university cancer institute & hosptial
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HanDan Central Hospital
Handan, Hebei, China
Handan First Hospital
Handan, Hebei, China
Bai Qiu'en International Peace Hospital
Shijiazhuang, Hebei, China
Henan University Huaihe Hospital
Kaifeng, Henan, China
The First Affiliated Hospital of Henan University of Science & Technology
Luoyang, Henan, China
Luoyang Central Hospital Affiliated to Zhengzhou University
Luoyang, Henan, China
Xinxiang Central Hospital
Xinxiang, Henan, China
The First Affiliated Hospital of Xinxiang Medical University
Xinxiang, Henan, China
Xinyang Central Hospital
Xinyang, Henan, China
People's Hospital of Zhengzhou
Zhengzhou, Henan, China
Henan Cancer Hospital
Zhengzhou, Henan, China
The First Hospital of Henan College of Traditional Chinese Medicine
Zhengzhou, Henan, China
Shandong Provincial Western Hospital
Jinan, Shandong, China
Qingdao Center Hospital
Qingdao, Shandong, China
Tai'an Central Hospital
Tai’an, Shandong, China
The 88th Hospital of People's Liberation Army
Tai’an, Shandong, China
People's Hospital of Xintai City
Tai’an, Shandong, China
Weifang No.2 People's Hospital
Weifang, Shandong, China
Weihai Municipal Hospital
Weihai, Shandong, China
Central Hospital of Zibo
Zibo, Shandong, China
Jincheng General Hospital
Jincheng, Shanxi, China
The Fourth People's Hospital of Linfen
Linfen, Shanxi, China
Traditional Chinese Hospital of Shanxi
Taiyuan, Shanxi, China
Yuncheng Central Hospital
Yuncheng, Shanxi, China
Chengdu Second People's Hospital
Chengdu, Sichuan, China
AVIC 363 Hospital
Chengdu, Sichuan, China
Teaching Hospital of Chengdu University of T.C.M.
Chengdu, Sichuan, China
The Second People's Hospital of Yibin
Yibin, Sichuan, China
Tianjin medical university cancer institute & hosptial
Tianjin, Tianjin Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Kuh-seng1.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.